One of the new directions in the study of reproductive disorders in obese women is the effect and receptor sensitivity of melatonin on the gonadotropic function of the pituitary gland and ovariogenesis, taking into account the chronology of «light pollution». At the present stage, there is very little literature on the influence of the aspects of «light pollution» on the problem of obesity and reproductive disorders in the literature. This review is an attempt to combine the above problem in terms of the impact of «light pollution» and the level of receptor sensitivity of melatonin in women of reproductive age with obesity. The literature search was carried out in Russian (eLibrary, CyberLeninka.ru) and international (PubMed, Cochrane Library) databases in Russian and English. Free access to the full text of the articles was a priority. The selection of sources was prioritized for the period from 2015 to 2019. However, given the insufficient knowledge of the chosen topic, the choice of sources was dated from 1992. The work was carried out as part of the study «Central and peripheral pathophysiological mechanisms of development of adipose tissue diseases, taking into account clinical and hormonal characteristics» 2020-2022.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926146 | PMC |
| http://dx.doi.org/10.14341/probl12710 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A BODIPY-Containing Covalent Organic Framework as a Highly Porous Photosensitizer for Environmental Remediation and Pollutants Adsorption.
Angew Chem Int Ed Engl
January 2025
Eberhard Karls Universität Tübingen: Eberhard Karls Universitat Tubingen, Institut für Organische Chemie, Auf der Morgenstelle 18, 72076, Tübingen, GERMANY.
The direct incorporation of borondipyrromethene (BODIPY) subunits into the structural backbone of covalent organic frameworks (COFs) gives facile access to porous photosensitizers but is still a challenging task. Here, we introduce β‑ketoenamine-linked BDP‑TFP‑COF, which crystallizes in AA‑stacking mode with hcb topology. A comprehensive characterization reveals high crystallinity and enhanced stability in a variety of solvents, excellent mesoporosity (SABET = 1042 m2 g-1), broad light absorption in the visible region, and red emission upon the exfoliation of few-layer COF nanosheets.
View Article and Find Full Text PDFBackground: Neurofilament light chain (NfL) is a fluid biomarker of axonal damage reported to be elevated in cases with dementia, and particularly in FTD. In this study we evaluate the performance of a recently developed NfL assay to be analyzed through the Lumipulse chemiluminescent platform, which is frequently available in clinical settings for the study of AD core biomarkers.
Method: We evaluated CSF NfL levels using the Lumipulse G600II platform (Fujirebio, Iberia) in 70 cases, including 33 patients with AD (supported by CSF biomarkers consistent with an A+T+(N)+ classification scheme), 26 with confirmed FTD (typical phenotype and CSF with a A-T- profile), and 11 controls.
Background: Alzheimer's disease (AD) impacts over 50 million individuals and imposes a substantial burden on patients, caregivers, and society at large. Recent research suggests that AD is a continuum comprising preclinical, prodromal, and dementia stages, with underlying pathology manifesting well before symptoms appear. Early and accurate diagnosis is therefore crucial for optimal clinical outcomes; yet current diagnostic methods, such as neuroimaging and cerebrospinal fluid lumbar puncture, are expensive and invasive.
View Article and Find Full Text PDFBiomarkers.
Alzheimers Dement
December 2024
University of North Texas Health Science Center, Fort Worth, TX, USA.
Background: Older African American (AA) and Hispanic American (HA) adults have a higher risk for Alzheimer's disease (AD) than older non-Hispanic white (NHW) adults. Cerebrovascular disease reflected by white matter hyperintensity (WMH) lesions on magnetic resonance imaging (MRI) may influence ADRD risk in these groups. Amyloid and tau PET data from studies of mostly NHW participants show a relationship between AD pathology and WMH lesions.
View Article and Find Full Text PDFBackground: With the emergence of anti-amyloid drugs, there is an increased need to determine the presence of brain amyloid in people using non-invasive, cost-effective biomarkers. The goal of this study was to determine the added and stand-alone value of plasma biomarkers for predicting positive amyloid PET in a mixed sample of Hispanic and non-Hispanic older adults.
Method: Participants (n=209) from the 1Florida ADRC at Mount Sinai Medical Center, Miami Beach had neurological and neuropsychological evaluations; MRI, rated positive (Hpc+) or negative (Hpc-) for hippocampal atrophy on visual read; amyloid PET brain scans, rated amyloid positive (A+) or negative (A-) on visual read; blood draws for APOE ε4 genotyping (e4+, e4-); and plasma biomarkers including Abeta 42/40 ratio (Quest Diagnostics), p-tau217 (ALZPath), glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) (Quanterix).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!